AGL39.71▼ -0.42 (-0.01%)AIRLINK189.85▲ 0.42 (0.00%)BOP9.83▼ -0.51 (-0.05%)CNERGY7.01▼ -0.2 (-0.03%)DCL10.24▲ 0.03 (0.00%)DFML41.31▼ -0.49 (-0.01%)DGKC105.99▼ -2.64 (-0.02%)FCCL37.72▼ -0.87 (-0.02%)FFBL93.41▲ 3.5 (0.04%)FFL15▼ -0.02 (0.00%)HUBC122.3▼ -0.93 (-0.01%)HUMNL14.31▼ -0.14 (-0.01%)KEL6.32▼ -0.02 (0.00%)KOSM8.12▼ -0.28 (-0.03%)MLCF48.78▼ -0.69 (-0.01%)NBP72.31▼ -2.51 (-0.03%)OGDC222.95▲ 9.54 (0.04%)PAEL33.62▲ 0.63 (0.02%)PIBTL9.67▲ 0.6 (0.07%)PPL201.45▲ 1.52 (0.01%)PRL33.8▼ -0.75 (-0.02%)PTC26.59▼ -0.62 (-0.02%)SEARL116.87▼ -1.32 (-0.01%)TELE9.63▼ -0.25 (-0.03%)TOMCL36.61▲ 1.19 (0.03%)TPLP11.95▼ -0.62 (-0.05%)TREET24.49▲ 2.2 (0.10%)TRG61.36▲ 0.46 (0.01%)UNITY36.06▼ -0.63 (-0.02%)WTL1.79▲ 0 (0.00%)

UK study finds mRNA vaccines biggest booster

Share
Tweet
WhatsApp
Share on Linkedin
[tta_listen_btn]

England’s Covid-19 prevalence rises, led by Delta not Omicron The prevalence of Covid-19 infections in England rose to around one in 60 people in the week ending November 27, led higher by the dominant Delta variant rather than the newly identified Omicron, Britain’s Office for National Statistics (ONS) has said.

The prevalence was up from one in 65 reported the previous week, the ONS said, adding that 99 per cent of all coronavirus infections which were sequenced were genetically compatible with the Delta variant.

Related Posts

Get Alerts